pharmaphorum

MAY 25, 2021

Dr Ignacio Medrano, chief medical officer and founder at Savana, said: “We are now able to teach a computer how to read records and turn free text into a database of clinical variables.”. Data collected like this is also acceptable to regulators, pointed out Medrano, meaning that it can be used during the clinical development process.

Big Data 135

Big Data Clinical Research Research Trials 135

Drug Discovery World

DECEMBER 27, 2023

Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

XTalks

MAY 9, 2024

How does Genmab foresee the next frontier of antibody research impacting the development of precision medicine, and what potential breakthroughs do you anticipate in this domain? Tahi Ahmadi: Two key areas where we anticipate breakthroughs are technological advancements and new modalities.

Antibody 52

Antibody Clinical Trials Clinical Trials Medicine 52

The Pharma Data

OCTOBER 25, 2020

BTI’s drug re-innovation approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices.

Trials 52

Trials Production FDA Approval Development 52

The Pharma Data

JANUARY 4, 2021

Barber’s work will give Kiromic a significant acceleration in the clinical development of its therapy platform and an even more significant advantage over its competitors. The pipeline development is leveraged through the Company’s proprietary target discovery engine called “DIAMOND.” “We believe Prof.

In-Vivo 40

In-Vivo Development Big Data Immune Response 40

Drug Discovery World

NOVEMBER 18, 2022

Overall, the WHO’s assessment of antibacterial products in clinical development 4 highlights the lack of activity in the sector, stating that the clinical pipeline and recently approved antibiotics “are insufficient to tackle the challenge of increasing emergence and spread of antimicrobial resistance.” .

Bacteria 52

Bacteria Drugs Development Research 52

XTalks

AUGUST 2, 2023

With Blackstone Life Sciences, up to €300 million (around $315 million USD) will be invested to accelerate pivotal studies and clinical development programs for formulating the subcutaneous delivery of the anti-CD38 antibody Sarclisa (isatuximab) for the treatment of multiple myeloma.

Sales 98

Sales Manufacturing FDA Approval Life Science 98